News U6

NMR signal enhancement of >50 000 times in fast dissolution dynamic nuclear polarization

Jaume Veciana, Scientific Director of NANBIOSIS-ICTS has participated in the research results published in the journal Chemical Communication, wich reports the synthesis and the study of a novel mixed biradical with BDPA and TEMPO radical units that are covalently bound by an ester group (BDPAesterTEMPO) as a polarizing agent for fast dissolution DNP. The biradical exhibits an extremely high DNP NMR enhancement of >50000 times, which constitutes one of the largest signal enhancements observed so far, to the best of our knowledge.

Some of the researchs were made taking advantage of the characterization facilities provided by ICTS NANBIOSIS.

For more information:

L. F. Pinto, I. Marín-Montesinos, V. Lloveras, J. L. Muñoz-Gómez, M. Pons, J. Veciana and J. Vidal-Gancedo*. Chem. Commun., 2017,53, 3757-3760. DOI: 10.1039/C7CC00635G

• Read More

NANOMOL group, coorditator of Unit 6 of NANBIOSIS has authored 26% of the scientific articles of ICMAB in NATURE

The Nature Index takes into account the published scientific articles from 1 February 2016 to 31 January 2017. This index is elaborated annually based on the affiliations of the authors of scientific articles published in a selection of 68 high-quality journals (http://www.natureindex.com/faq#journals)

CSIC appears as the first Spanish research centre in this ranking and occupies position number 38 in the global ranking of 500 research centres worldwide, while ICMAB occupies the first position within the CSIC centre, taking into account the corrected index WFC that shares the work between the different co-authoring institutions and corrects for the overrepresentation of some fields. Thus, ICMAB appears in the Nature index with a total of 42 articles out of which 12 have been authored by researchers of NANOMOL, showing a significant contribution (26% of the publications contained in this list) to the leadership of ICMAB in excellence in Science.

Some of the published papers were made taking advantage of the characterization facilities provided by ICTS NANBIOSIS

NANOMOL is a research group with wide expertise and recognized excellence in the synthesis, processing and study of molecular and polymeric materials with chemical, electronic, magnetic and biomedical properties, that continuously generate new knowledge in its basic and applied research projects regarding the micro and nano structuring of molecular materials. NANOMOL offers this knowledge to improve the properties of products manufactured in diverse sectors, such as chemicals, pharmaceuticals and electronics, thereby contributing to increasing their added value. NANOMOL is a research group actively involved in implementing nanotechnology and sustainable and economically efficient technologies for preparing advanced functional molecular materials. It is also the group coordinator of Unit 6 of NANBIOSIS and its Leader group, Dr. Jaume Veciana, is the Scientific Director of NANBIOSIS-ICTS

• Read More

NANBIOSIS Scientific Director Dr. Jaume Veciana received a Mention of Honor for his dedication to NANBIOSIS

On April 22, Dr. Jaume Veciana received a Mention of Honor from the current President of Extremadura, Guillermo Fernández Vara, during the celebration of the X Anniversary of the Center for Minimally Invasive Surgery “Jesus Usón” for his commitment, effort and dedication in the creation of the Singular Scientific Technological Infrastructures (ICTS) NANBIOSIS, in collaboration with the Center for Biomedical Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN).

Further information:

• Read More

Materials for Biomedical Applications Scientific School (BIOMAT-2017)

Registration is now open for the Scientific School on Materials for Biomedical Applications (BIOMAT-2017) that will take place on 19th-22nd of June 2017 in the UAB Campus (Barcelona). This school is organized by ICMAB-CSIC and it is included in the Severo Ochoa activities of the Institute.

The school is addressed to last year undergraduate, master and PhD students, who are interested in the development of materials for biomedical applications. The aim of the school is to present the design, development and application of new materials for a wide range of biomedical applications.

The school includes lectures from international and local scientists, hands-on and management activities and practical sessions. One of the practical sessions will take place at Unit 6 of NANBIOSIS and will be directed to the preparation and characterization of particulate nanomaterials with biomedical applications.

This Scientific School is an optimal opportunity to discover, learn and practice on material science focusing on fundamental science and applied research in the field of biomedicine.

There will be grants for students covering the fees of the summer school.

For further details and registration please go to:

https://congresses.icmab.es/matbio2017/

Registration deadline: 21st May 2017

There are only 50 places available, secure yours with an early registration.

• Read More

Validation of a drug for foot ulcers in collaboration with Cuba

Nanomol, (Unit 6 of NANBIOSIS) has announced in Cuba that the process of clinical validation of a new drug developed and patented in collaboration with Center of Genetic Engineering and Biotechnology of Cuba, integrated in BioCubaFarma, has been initiated. The new drug is designed to improve the healing of foot ulcer in diabetics and could be on the market in five years.

The collaboration of the Center for Genetic Engineering and Biotechnology of Cuba with Nanomol, coordinating group of Unit 6 of NANBIOSIS, began in 2010. Cuban researchers had developed an effective product in wound healing in diabetics but the product had to be Administered with injections in the affected area. Nanomol obtained a nanoformulation with which it is possible to integrate the protein in a nanovesícula, so that the active principle of its degradation is protected once it is applied in the wound and, in addition, is obtained that the protein is released of suitable form. The results of the work have resulted in a patent and currently the process of validation and scaling of pharmaceutical production is being carried out to bring the product to market.

U6 of NANBIOSIS has played an important role in the development of this potential nanomedicine since it enabled a detailed characterization of several physico-chemical properties of the multifunctional nanovesicles used to construct it.

Validation of a drug for foot ulcers in collaboration with Cuba

• Read More

Lipid-based Nanovesicles for Nanomedicine

Jaume Veciana and Nora Ventosa, Scientific Directors of Unit 6 of NANBIOSIS together with other researchers from NANOMOL group, coordinator of Unit 6 of NANBIOSIS, has recently published an interesting review article in the journal Chemical Society Reviews.

This review presents the large plethora of lipid-based nanovescicles available nowadays, focusing on a new generation of non-liposomal L-NVs and showing their similarities and differences with respect to their ancestors (liposomes). Since the overspread of a nanomaterial to the market is also strongly dependent on the availability of technological-scale preparation methods, it also extensively review the current approaches exploited for L-NV production. The most cutting-edge approaches for their preparation based on compressed fluid (CF) technologies is highlighted since they show the potential to represent a game-change in the production of L-NVs, favoring their step from the bench to the market. Finally, this review briefly discusses L-NV applications in nanomedicine looking also for their future perspectives.

Article of reference: N.Grimaldi, F. da Silva, N.V. Segovia, L. Ferrer-Tasies, S. Sala, J. Veciana,^*and N. Ventosa^*, Chem. Soc. Rev., 2016, 45, 6520—6545

Lipid-based Nanovesicles for Nanomedicine

• Read More

Extraordinary doctoral award

Ingrid Cabrera, member of the NANOMOL group that coordinates Unit 6 of NANBIOSIS, has obtained the extraordinary doctoral award from the Universitat Autònoma de Barcelona for her thesis “Nanovesicle-bioactive conjugates to be used as nanomedicines, prepared by a one-step scalable method Using CO₂-expanded solvents“.

This thesis was directed by Jaume Veciana, Scientific Director of NANBIOSIS and Nora Ventosa, Scientific Director of Unit 6 of NANBIOSIS.

The main objectives of the PhD Thesis of Dr. Ingrid Cabrera were the preparation and study of multifunctional nanovesicle based nanoformulation of alfa-galactosidase for the treatment of Fabry desease as well as of another multifunctional nanovesicle based nanoformulation of epidermal growth factor for the treatment of complex wounds. Both nanoformulations were prepared by a one-step procedure using compressed fluids at U6 of Nanbiosis. This platform also provided many nanoparticles characterization facilities that enabled to obtain important information on the supramolecular organization and characteristics of the produced multifunctional nanovesicles that were key for understanding their biological activities.

• Read More

Congress Excellence 2016

The Spanish University with the highest number of scientifically distinguished research institutes is Universitat Autònoma de Barcelona with five Centres of Excellence “Severo Ochoa” and two Units of Excellence “María de Maeztu”.

ICMAB-CSIC, Research Institute housing unit 6 of NANBIOSIS and one of the five Severo Ochoa Centers of UAB organised the Congress Excellence 2016

More information

• Read More

Chemical control over the energy-level alignment in a two-terminal junction

In a study published in the journal Nature Communications, researchers of Nanomol group, led by the Scientific Director of Unit 6 of NANBIOSIS, Dr. Jaume Veciana have shown that the alignment of the energy levels in molecular bonds based on sel- assembled monolayers can be regulated through only chemical modifications.

The energy-level alignment of molecular transistors can be controlled by external gating to move molecular orbitals with respect to the Fermi levels of the source and drain electrodes. Two-terminal molecular tunnelling junctions, however, lack a gate electrode and suffer from Fermi-level pinning, making it difficult to control the energy-level alignment of the system. Here is where the researchers report an enhancement of 2 orders of magnitude of the tunnelling current in a two terminal junction via chemical molecular orbital control, changing chemically the molecular component between a stable radical and its non-radical form without altering the supramolecular structure of the junction. These are the findings that demonstrate that the energy-level alignment in self-assembled monolayer-based junctions can be regulated by purely chemical modifications, which seems an attractive alternative to control the electrical properties of two terminal junctions.

Article of reference:

Chemical control over the energy-level alignment in a two-terminal junction. Li Yuan, Carlos Franco, Núria Crivillers, Marta Mas-Torrent, Liang Cao, C.S. Suchand Sangeeth, Concepció Rovira, Jaume Veciana*, Christian A. Nijhuis*. Nature Communications.

Nanbiosis-U6-Chemical control over the energy-level alignment in a two-terminal junction

• Read More

Synergies produced in NANBIOSIS multiply the value of its services and allow its users to have results with faster and superior reliability due to proven experience of the scientists and technicians involved, says Jaume Veciana, Scientific Director of NANBIOSIS, in an interview at July 2016 CIBER-BBN Bulletin.

In this interview, Jaume Veciana assesses the functioning of this Singular Scientific-Technical Infrastructure and its contribution to research and anticipates some of the guidelines of the NANBIOSIS Strategic Plan 2017-2020, which includes a clear commitment to internationalization.

“The scientific-technical capabilities available at NANBIOSIS must be exploited without limitation to our country. Therefore we are clear that we must promote the activity of NANBIOSIS both academic and industrial sector in the European Union and other countries, either directly or in association with other similar organizations actions. Some such initiatives have already started but we believe it should be given further boost to internationalization. As an example we can mention the participation in the European project INFRAIA that aims to integrate regional and national research infrastructures existing in Europe under the Horizon 2020”

Professor Veciana also talks about NANOMOL, the research group coordinator of Unit 6 of NANBIOSIS, and the main applications of their findings in the fields of nanomedicine and biomaterials.

To know more

Synergies produced in NANBIOSIS multiply the value of its services and allow its users to have results with faster and superior reliability due to proven experience of the scientists and technicians involved, says Jaume Veciana, Scientific Director of NANBIOSIS, in an interview at July 2016 CIBER-BBN Bulletin.

• Read More

You are here : Home / News U6 (Page 10)